KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cost of Revenue (2016 - 2025)

Charles River Laboratories International has reported Cost of Revenue over the past 17 years, most recently at $249.3 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 81.75% year-over-year to $249.3 million; the TTM value through Dec 2025 reached $1.8 billion, down 27.18%, while the annual FY2025 figure was $576.2 million, 66.05% down from the prior year.
  • Cost of Revenue for Q4 2025 was $249.3 million at Charles River Laboratories International, down from $408.1 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.4 billion in Q4 2024 and troughed at -$1.0 billion in Q4 2021.
  • A 5-year average of $396.2 million and a median of $455.4 million in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: soared 653.48% in 2023 and later crashed 81.75% in 2025.
  • Year by year, Cost of Revenue stood at -$1.0 billion in 2021, then soared by 160.23% to $603.1 million in 2022, then plummeted by 47.19% to $318.5 million in 2023, then surged by 328.74% to $1.4 billion in 2024, then crashed by 81.75% to $249.3 million in 2025.
  • Business Quant data shows Cost of Revenue for CRL at $249.3 million in Q4 2025, $408.1 million in Q3 2025, and $584.9 million in Q2 2025.